An in vitro study evaluating the effects of ApoE isoforms on α-synuclein aggregation showed that ApoE4 increases aggregation of α-synuclein more than other isoforms (110) in a mechanism resembling Aβ management in AD. This evidence concerns the gene APOE and Alzheimer disease.